Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03495154 · ClinicalTrials.gov registry record · NA
Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair
A NA study, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT03495154 is a NA study that has completed, run by Medtronic - MITG. The registered enrollment target is 145 participants.
The verdict
NCT03495154, a NA study, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
A multi-center post-market single arm prospective study of Parietene™ DS Composite Mesh in subjects undergoing ventral hernia repair to confirm its clinical safety and performance in the short (1, 3 months), mid (12 months) and long term (24 months)
Interventions
- DEVICE Parietene DS Composite Mesh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2022-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03495154
The ClinicalTrials.gov registry entry for NCT03495154 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Parietene DS Composite Mesh is the first listed.
NCT03495154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03495154 about?
NCT03495154 is a clinical study titled "Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair". A multi-center post-market single arm prospective study of Parietene™ DS Composite Mesh in subjects undergoing ventral hernia repair to confirm its clinical safety and performance in the short (1, 3 months), mid (12 months) and long term (24 months)
What is the current status of trial NCT03495154?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2018-06-21. Estimated completion is 2022-07-06.
What interventions are being tested in trial NCT03495154?
The interventions under investigation include: Parietene DS Composite Mesh (DEVICE).
Who is sponsoring clinical trial NCT03495154?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.